Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 44, 2020 - Issue 4
138
Views
2
CrossRef citations to date
0
Altmetric
Brief Report

Hb Manitoba [α102(G9)Ser→Arg] in Pasifika: Tongan Case Report

ORCID Icon & ORCID Icon
Pages 290-293 | Received 07 May 2020, Accepted 15 Jun 2020, Published online: 03 Jul 2020
 

Abstract

Hb Manitoba [α102(G9)Ser→Arg] results from an AGC>CGC or AGC>AGA substitution at codon 102 of the HBA1 or HBA2 genes. The variant is mildly unstable but carriers typically have normal clinical presentation and hematological profile. Hb Manitoba has not been reported in Pasifika of Tongan, Samoan or New Zealand (NZ) Māori descent before. The cases presented here support the findings from existing literature but include results from alternative methodology including capillary zone electrophoresis (CZE), which may slightly underestimate the true variant percentage. The subject of our case report, a Tongan male with microcytic indices, was shown to be heterozygous for Hb Manitoba III (HBA2: c.309C>A) coinherited with the –α3.7 (rightward) deletion.

Acknowledgments

The authors thank Professor Stephen O. Brennan, Canterbury Health Laboratories, Christchurch, for the mutation analysis.

Disclosure statement

The authors report no conflict of interest. The authors alone are responsible for the content and writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.